COTERRA ENERGY INC (CTRA)

US1270971039 - Common Stock

23.68  +0.01 (+0.04%)

After market: 23.65 -0.03 (-0.13%)

Fundamental Rating

6

Overall CTRA gets a fundamental rating of 6 out of 10. We evaluated CTRA against 205 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and the financial health of CTRA get a neutral evaluation. Nothing too spectacular is happening here. CTRA has a correct valuation and a medium growth rate.



6

1. Profitability

1.1 Basic Checks

In the past year CTRA was profitable.
In the past year CTRA had a positive cash flow from operations.
CTRA had positive earnings in each of the past 5 years.
In the past 5 years CTRA always reported a positive cash flow from operatings.

1.2 Ratios

Looking at the Return On Assets, with a value of 6.15%, CTRA is in line with its industry, outperforming 56.37% of the companies in the same industry.
Looking at the Return On Equity, with a value of 9.48%, CTRA is in line with its industry, outperforming 42.16% of the companies in the same industry.
With a Return On Invested Capital value of 6.67%, CTRA perfoms like the industry average, outperforming 47.55% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CTRA is significantly below the industry average of 29.02%.
The 3 year average ROIC (12.47%) for CTRA is well above the current ROIC(6.67%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 6.15%
ROE 9.48%
ROIC 6.67%
ROA(3y)11.29%
ROA(5y)10.7%
ROE(3y)18.09%
ROE(5y)18.99%
ROIC(3y)12.47%
ROIC(5y)11.86%

1.3 Margins

CTRA has a better Profit Margin (21.86%) than 69.12% of its industry peers.
CTRA's Profit Margin has been stable in the last couple of years.
Looking at the Operating Margin, with a value of 28.96%, CTRA is in the better half of the industry, outperforming 61.76% of the companies in the same industry.
CTRA's Operating Margin has been stable in the last couple of years.
CTRA's Gross Margin of 81.02% is amongst the best of the industry. CTRA outperforms 90.69% of its industry peers.
CTRA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 28.96%
PM (TTM) 21.86%
GM 81.02%
OM growth 3Y21.75%
OM growth 5Y0.25%
PM growth 3Y26.06%
PM growth 5Y1.48%
GM growth 3Y13.51%
GM growth 5Y4.53%

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CTRA is still creating some value.
The number of shares outstanding for CTRA has been reduced compared to 1 year ago.
Compared to 5 years ago, CTRA has more shares outstanding
Compared to 1 year ago, CTRA has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 2.46 indicates that CTRA is not a great score, but indicates only limited risk for bankruptcy at the moment.
CTRA has a better Altman-Z score (2.46) than 71.57% of its industry peers.
The Debt to FCF ratio of CTRA is 1.85, which is an excellent value as it means it would take CTRA, only 1.85 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.85, CTRA is in the better half of the industry, outperforming 78.43% of the companies in the same industry.
A Debt/Equity ratio of 0.16 indicates that CTRA is not too dependend on debt financing.
CTRA's Debt to Equity ratio of 0.16 is fine compared to the rest of the industry. CTRA outperforms 72.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.85
Altman-Z 2.46
ROIC/WACC0.78
WACC8.52%

2.3 Liquidity

A Current Ratio of 1.61 indicates that CTRA should not have too much problems paying its short term obligations.
CTRA's Current ratio of 1.61 is fine compared to the rest of the industry. CTRA outperforms 67.16% of its industry peers.
A Quick Ratio of 1.56 indicates that CTRA should not have too much problems paying its short term obligations.
CTRA has a Quick ratio of 1.56. This is in the better half of the industry: CTRA outperforms 70.59% of its industry peers.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 1.56

6

3. Growth

3.1 Past

CTRA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -41.10%.
The Earnings Per Share has been growing by 13.51% on average over the past years. This is quite good.
The Revenue for CTRA has decreased by -14.23% in the past year. This is quite bad
CTRA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.00% yearly.
EPS 1Y (TTM)-41.1%
EPS 3Y61.63%
EPS 5Y13.51%
EPS Q2Q%-36%
Revenue 1Y (TTM)-14.23%
Revenue growth 3Y59.17%
Revenue growth 5Y22%
Sales Q2Q%0.22%

3.2 Future

Based on estimates for the next years, CTRA will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.90% on average per year.
The Revenue is expected to grow by 11.71% on average over the next years. This is quite good.
EPS Next Y-27.35%
EPS Next 2Y13.16%
EPS Next 3Y18.46%
EPS Next 5Y12.9%
Revenue Next Year-6.77%
Revenue Next 2Y12.64%
Revenue Next 3Y11.71%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

5

4. Valuation

4.1 Price/Earnings Ratio

CTRA is valuated correctly with a Price/Earnings ratio of 13.77.
The rest of the industry has a similar Price/Earnings ratio as CTRA.
When comparing the Price/Earnings ratio of CTRA to the average of the S&P500 Index (27.73), we can say CTRA is valued rather cheaply.
CTRA is valuated reasonably with a Price/Forward Earnings ratio of 8.11.
CTRA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CTRA is cheaper than 69.12% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.83. CTRA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 13.77
Fwd PE 8.11

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CTRA is valued a bit cheaper than 61.27% of the companies in the same industry.
CTRA's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 15.52
EV/EBITDA 5.43

4.3 Compensation for Growth

CTRA has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CTRA's earnings are expected to grow with 18.46% in the coming years.
PEG (NY)N/A
PEG (5Y)1.02
EPS Next 2Y13.16%
EPS Next 3Y18.46%

5

5. Dividend

5.1 Amount

CTRA has a Yearly Dividend Yield of 3.55%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 7.08, CTRA has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.34, CTRA pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.55%

5.2 History

On average, the dividend of CTRA grows each year by 35.96%, which is quite nice.
CTRA has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)35.96%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

CTRA pays out 50.20% of its income as dividend. This is a bit on the high side, but may be sustainable.
CTRA's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP50.2%
EPS Next 2Y13.16%
EPS Next 3Y18.46%

COTERRA ENERGY INC

NYSE:CTRA (12/20/2024, 8:04:20 PM)

After market: 23.65 -0.03 (-0.13%)

23.68

+0.01 (+0.04%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)10-31 2024-10-31/amc
Earnings (Next)02-20 2025-02-20/amc
Inst Owners89.85%
Inst Owner Change0%
Ins Owners0.98%
Ins Owner Change-4.96%
Market Cap17.44B
Analysts81.94
Price Target33.23 (40.33%)
Short Float %2.37%
Short Ratio3.01
Dividend
Industry RankSector Rank
Dividend Yield 3.55%
Dividend Growth(5Y)35.96%
DP50.2%
Div Incr Years0
Div Non Decr Years0
Ex-Date11-14 2024-11-14 (0.21)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.54%
Min EPS beat(2)-7.78%
Max EPS beat(2)-7.3%
EPS beat(4)1
Avg EPS beat(4)-0.48%
Min EPS beat(4)-7.78%
Max EPS beat(4)20.53%
EPS beat(8)5
Avg EPS beat(8)5.77%
EPS beat(12)8
Avg EPS beat(12)4.53%
EPS beat(16)10
Avg EPS beat(16)2.49%
Revenue beat(2)1
Avg Revenue beat(2)-1.97%
Min Revenue beat(2)-6.2%
Max Revenue beat(2)2.26%
Revenue beat(4)3
Avg Revenue beat(4)-0.1%
Min Revenue beat(4)-6.2%
Max Revenue beat(4)2.57%
Revenue beat(8)5
Avg Revenue beat(8)0.32%
Revenue beat(12)8
Avg Revenue beat(12)2.86%
Revenue beat(16)9
Avg Revenue beat(16)-1.37%
PT rev (1m)5.29%
PT rev (3m)-1.33%
EPS NQ rev (1m)-1.61%
EPS NQ rev (3m)-28.62%
EPS NY rev (1m)0.2%
EPS NY rev (3m)-17.07%
Revenue NQ rev (1m)-0.49%
Revenue NQ rev (3m)-10.82%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-4.1%
Valuation
Industry RankSector Rank
PE 13.77
Fwd PE 8.11
P/S 3.08
P/FCF 15.52
P/OCF 5.95
P/B 1.34
P/tB 1.34
EV/EBITDA 5.43
EPS(TTM)1.72
EY7.26%
EPS(NY)2.92
Fwd EY12.33%
FCF(TTM)1.53
FCFY6.45%
OCF(TTM)3.98
OCFY16.8%
SpS7.68
BVpS17.71
TBVpS17.71
PEG (NY)N/A
PEG (5Y)1.02
Profitability
Industry RankSector Rank
ROA 6.15%
ROE 9.48%
ROCE 8.61%
ROIC 6.67%
ROICexc 6.98%
ROICexgc 6.98%
OM 28.96%
PM (TTM) 21.86%
GM 81.02%
FCFM 19.86%
ROA(3y)11.29%
ROA(5y)10.7%
ROE(3y)18.09%
ROE(5y)18.99%
ROIC(3y)12.47%
ROIC(5y)11.86%
ROICexc(3y)13.03%
ROICexc(5y)12.4%
ROICexgc(3y)13.03%
ROICexgc(5y)12.4%
ROCE(3y)16.09%
ROCE(5y)15.3%
ROICexcg growth 3Y17.75%
ROICexcg growth 5Y-9.68%
ROICexc growth 3Y17.75%
ROICexc growth 5Y-9.68%
OM growth 3Y21.75%
OM growth 5Y0.25%
PM growth 3Y26.06%
PM growth 5Y1.48%
GM growth 3Y13.51%
GM growth 5Y4.53%
F-Score5
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.85
Debt/EBITDA 0.6
Cap/Depr 100.28%
Cap/Sales 31.9%
Interest Coverage 250
Cash Conversion 85.17%
Profit Quality 90.87%
Current Ratio 1.61
Quick Ratio 1.56
Altman-Z 2.46
F-Score5
WACC8.52%
ROIC/WACC0.78
Cap/Depr(3y)112.97%
Cap/Depr(5y)136.11%
Cap/Sales(3y)25.16%
Cap/Sales(5y)30.58%
Profit Quality(3y)89.89%
Profit Quality(5y)93.42%
High Growth Momentum
Growth
EPS 1Y (TTM)-41.1%
EPS 3Y61.63%
EPS 5Y13.51%
EPS Q2Q%-36%
EPS Next Y-27.35%
EPS Next 2Y13.16%
EPS Next 3Y18.46%
EPS Next 5Y12.9%
Revenue 1Y (TTM)-14.23%
Revenue growth 3Y59.17%
Revenue growth 5Y22%
Sales Q2Q%0.22%
Revenue Next Year-6.77%
Revenue Next 2Y12.64%
Revenue Next 3Y11.71%
Revenue Next 5YN/A
EBIT growth 1Y-43.09%
EBIT growth 3Y93.78%
EBIT growth 5Y22.31%
EBIT Next Year56.47%
EBIT Next 3Y37.05%
EBIT Next 5Y23.42%
FCF growth 1Y-67.42%
FCF growth 3Y97.49%
FCF growth 5Y49.26%
OCF growth 1Y-40.52%
OCF growth 3Y67.51%
OCF growth 5Y27.05%